Procurement Summary
Country : USA
Summary : NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
Deadline : 07 May 2023
Other Information
Notice Type : Tender
TOT Ref.No.: 42719070
Document Ref. No. : PA-20-194
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV
Tender Details
Tender are invited for NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
CFDA Number : 93.113 -- Environmental Health93.172 -- Human Genome Research93.173 -- Research Related to Deafness and Communication Disorders93.242 -- Mental Health Research Grants93.273 -- Alcohol Research Programs93.279 -- Drug Abuse and Addiction Research Programs93.361 -- Nursing Research93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research93.855 -- Allergy and Infectious Diseases Research93.866 -- Aging Research93.867 -- Vision Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: May 07, 2023
Posted Date : May 07, 2020
Description: The NIH Exploratory/Developmental Grant supports exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research. This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. Applicants should note that some ICs (see Related Notices) only accept applications proposing mechanistic studies that meet NIH`s definition of a clinical trial through this funding opportunity announcement.
Documents
Tender Notice